Cholangiocarcinoma Market

1
CHOLANGIOCARCINOMA(CCA)

• Market Insights, Epidemiology, and Market
  Forecast- 2028

2
CHOLANGIOCARCINOMA (CCA)

• DelveInsight 2019 All rights reserved

3
CCA EPIDEMIOLOGY
EU-5 Incidence
Diagnosed
Among the EU5 countries, Germany had the highest
CCA incident population with 4,471 cases.
Cholangiocarcinoma total diagnosed incident
population in the 7MM was 18,470 in 2017.
Prevalence
US Incidence
Males are more prone to Cholangiocarcinoma as
compared to females among all countries.
Among all the countries, the higher
Cholangiocarcinoma incidence was 6,768 cases in
the US in 2017.

• DelveInsight 2019 All rights reserved

4
Cholangiocarcinoma Market Outlook
01
02
03
04
05
Cholangiocarcinoma market size in the 7MM was
found to USD 379.57 million in 2017 for the study
period (2017-2028).
CCA market size in Germany was found to be
highest with USD 82.46 million in 2017, whereas
Spain has the lowest share with USD 3.69 million
in 2017.
Among 7MM the United States accounts for the
highest CCA market size in comparison with EU-5
and Japan.
Cholangiocarcinoma market size for early stage
includes surgery with chemotherapy and
chemoradiation therapy.
The launch of various multiple-stage pipeline
products will significantly revolutionize CCA
market in future.
7MM includes- United States EU 5 (Germany,
France, Spain, Italy, United Kingdom) Japan.
4
www.website.com

• DelveInsight 2019 All rights reserved

5
CCA Emerging Drugs and Companies
Drug- Pemigatinib Company- Incyte Corporation
Drug- Regorafenib Company- Bayer
03
01
Drug- Entrectinib Company- Roche
Drug- Ivosidenib Company- Agios Pharmaceuticals
02
04

• DelveInsight 2019 All rights reserved

6
Complete Information
For complete information on
Cholangiocarcinoma Market Insights, Epidemiology
Market Forecast-2028 please click the link
below
CLICK HERE
OR
Write Us At 
info_at_delveinsight.com

• DelveInsight 2019 All rights reserved

7
About DelveInsight
ABOUT
VISION
MISSION
To be the most trusted market research business
consulting firm in the world and to continue
enable the Pharma Bio-Tech companies to achieve
their goals with the best strategic insight and
competitive solution. The vision also is
inclusive of becoming a one-stop solution
provider for the entire gamut of drug development
process.
DelveInsight is a premier Business Consulting and
Market Research firm focused exclusively on the
life science segment. With a wide array of smart
end-to-end solutions, the firm helps the global
Pharmaceutical and Bio-Tech companies formulate
prudent business decisions for improving their
performances to stay ahead of the competitors.
To provide insights across the value chain and
helping the organization to take a prudent
business decision through the use and analysis of
actionable market intelligence. The mission also
is to provide the most effective result and
efficient service with utmost client care for
maintaining a long-term relationship with them.

• DelveInsight 2019 All rights reserved

8
Service Offerings by DelveInsight
1
5
FORECASTING
OPPORTUNITY ASSESSMENT
2
6
PIPELINE
REPORT STORE
3
7
CONSULTING
COMPETITIVE ANALYSIS
8
4
PHARMDELVE
MARKET INTELLIGENCE

• DelveInsight 2019 All rights reserved

8
9
Contact Us
info_at_delveinsight.com
blog/delveInsight/
twitter/delveInsight
91-11-4568 9769
LinkedIn/delveInsight
www.delveinsight.com

• DelveInsight 2019 All rights reserved

10
Thank You